Mark Zimmerman

Dana-Farber Cancer Institute

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (9)

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (9)

Olaf Merkel

Associate Prof. Dr.

Medical University of Vienna

AUSTRIA

View details

Martin Janz

Max Delbrück Centrum für Molekulare Medizin Berlin Buch

GERMANY

View details

Daniel Carter

University of Technology, Sydney

AUSTRALIA

View details

Frank Speleman

Ghent University

BELGIUM

View details

Tero Aittokallio

University of Helsinki

FINLAND

View details

Holger Sudhoff

Professor and Chairman

Bielefeld University

GERMANY

View details

Marc Mansour

Professor

University College London

UNITED KINGDOM

View details

Sarah Gendreizig

Bielefeld University

GERMANY

View details

Kaat Durinck

professor (tenure track)

Ghent University

BELGIUM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mark Zimmerman

Research Interests

Explore related searches

Contact this professor

Articles (9)

Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia

Genetic predisposition to neuroblastoma results from a regulatory polymorphism that promotes the adrenergic cell state

p53 Pathway Inactivation Drives SMARCB1-deficient p53-wildtype Epithelioid Sarcoma Onset Indicating Therapeutic Vulnerability Through MDM2 Inhibition

Intrinsic transcriptional heterogeneity in neuroblastoma guides mechanistic and therapeutic insights

Synergistic melanoma cell death mediated by inhibition of both MCL1 and BCL2 in high-risk tumors driven by NF1/PTEN loss

Super-enhancer-based identification of a BATF3/IL-2R-module reveals vulnerabilities in anaplastic large cell lymphoma.

MEIS2 Is an Adrenergic Core Regulatory Transcription Factor Involved in Early Initiation of TH-MYCN-Driven Neuroblastoma Formation

Retinoic acid rewires the adrenergic core regulatory circuitry of childhood neuroblastoma

ARID1A loss in neuroblastoma promotes the adrenergic-to-mesenchymal transition by regulating enhancer-mediated gene expression

Collaborators (9)

Olaf Merkel

Martin Janz

Daniel Carter

Frank Speleman

Tero Aittokallio

Holger Sudhoff

Marc Mansour

Sarah Gendreizig

Kaat Durinck

Make your next move.